Press Releases from BioMedReports (1 total)
CEO of emerging NanoAntibiotics says firm is poised for growth in biotech’s po …
Jonathan Adams is CEO of NanoAntibiotics, Inc. (OTCQB:NNAB [nanoantibiotics.com], which will soon change its name to BioVie. He has been working in pharma/biotech since graduating…
Go To Page:
